Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.

Tang C, Lee AS, Volkmer JP, Sahoo D, Nag D, Mosley AR, Inlay MA, Ardehali R, Chavez SL, Pera RR, Behr B, Wu JC, Weissman IL, Drukker M.

Nat Biotechnol. 2011 Aug 14;29(9):829-34. doi: 10.1038/nbt.1947.

2.

Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces.

Venable A, Mitalipova M, Lyons I, Jones K, Shin S, Pierce M, Stice S.

BMC Dev Biol. 2005 Jul 21;5:15.

3.

Toward safer regenerative medicine.

Andrews PW.

Nat Biotechnol. 2011 Sep 8;29(9):803-5. doi: 10.1038/nbt.1974. No abstract available.

PMID:
21904323
4.

Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.

Lee MO, Moon SH, Jeong HC, Yi JY, Lee TH, Shim SH, Rhee YH, Lee SH, Oh SJ, Lee MY, Han MJ, Cho YS, Chung HM, Kim KS, Cha HJ.

Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):E3281-90. doi: 10.1073/pnas.1303669110. Epub 2013 Aug 5.

5.

Enrichment and purging of human embryonic stem cells by detection of cell surface antigens using the monoclonal antibodies TG30 and GCTM-2.

Polanco JC, Wang B, Zhou Q, Chy H, O'Brien C, Laslett AL.

J Vis Exp. 2013 Dec 6;(82):50856. doi: 10.3791/50856.

6.
7.

Glycan stem-cell markers are specifically expressed by spermatogonia in the adult non-human primate testis.

Müller T, Eildermann K, Dhir R, Schlatt S, Behr R.

Hum Reprod. 2008 Oct;23(10):2292-8. doi: 10.1093/humrep/den253. Epub 2008 Jul 10.

8.

Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells.

Nagaoka M, Kobayashi M, Kawai C, Mallanna SK, Duncan SA.

PLoS One. 2015 Aug 26;10(8):e0136350. doi: 10.1371/journal.pone.0136350. eCollection 2015 Aug 26.

9.

Cell surface markers in human embryonic stem cells.

Rao RR, Johnson AV, Stice SL.

Methods Mol Biol. 2007;407:51-61. doi: 10.1007/978-1-59745-536-7_5.

PMID:
18453248
10.
11.

Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.

Stachelscheid H, Wulf-Goldenberg A, Eckert K, Jensen J, Edsbagge J, Björquist P, Rivero M, Strehl R, Jozefczuk J, Prigione A, Adjaye J, Urbaniak T, Bussmann P, Zeilinger K, Gerlach JC.

J Tissue Eng Regen Med. 2013 Sep;7(9):729-41. doi: 10.1002/term.1467. Epub 2012 Mar 21.

PMID:
22438087
12.

Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment.

Stewart MH, Bossé M, Chadwick K, Menendez P, Bendall SC, Bhatia M.

Nat Methods. 2006 Oct;3(10):807-15.

PMID:
16990813
13.

STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation.

Choi SW, Shin TH, Uddin MH, Shin JH, Kang TW, Lee BC, Kim HS, Seo Y, Shams S, Jung YK, Kang KS.

Oncotarget. 2016 Jan 19;7(3):2684-95. doi: 10.18632/oncotarget.6472.

15.

Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.

Zhao L, Teklemariam T, Hantash BM.

Stem Cell Res. 2014 Sep;13(2):342-54. doi: 10.1016/j.scr.2014.08.004. Epub 2014 Aug 19.

16.

Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.

Polanco JC, Ho MS, Wang B, Zhou Q, Wolvetang E, Mason E, Wells CA, Kolle G, Grimmond SM, Bertoncello I, O'Brien C, Laslett AL.

Stem Cells. 2013 Aug;31(8):1498-510. doi: 10.1002/stem.1425.

17.

Expression and co-expression of surface markers of pluripotency on human amniotic cells cultured in different growth media.

Bryzek A, Czekaj P, Plewka D, Komarska H, Tomsia M, Lesiak M, Sieroń AL, Sikora J, Kopaczka K.

Ginekol Pol. 2013 Dec;84(12):1012-24.

PMID:
24505948
18.

Derivation of embryonic stem cell line from frozen human embryos and neural differentiation.

Tan JC, Li Y, Qu WY, Liu LY, Jiang L, Sun KL.

Neuroreport. 2008 Oct 8;19(15):1451-5. doi: 10.1097/WNR.0b013e32830e4c35.

PMID:
18797296
19.

Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells.

Choi HS, Kim H, Won A, Kim JJ, Son CY, Kim KS, Ko JH, Lee MY, Kim CH, Ryu CJ.

Cell Tissue Res. 2008 Aug;333(2):197-206. doi: 10.1007/s00441-008-0632-6. Epub 2008 Jun 17.

PMID:
18560898
20.

Brief report: L1 cell adhesion molecule, a novel surface molecule of human embryonic stem cells, is essential for self-renewal and pluripotency.

Son YS, Seong RH, Ryu CJ, Cho YS, Bae KH, Chung SJ, Lee B, Min JK, Hong HJ.

Stem Cells. 2011 Dec;29(12):2094-9. doi: 10.1002/stem.754.

Supplemental Content

Support Center